Clinical Trials on BRCA1/2 Negative in Finland
Total 516 results
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedBreast Cancer | brca1 Mutation Carrier | brca2 Mutation CarrierUnited States
-
Women and Infants Hospital of Rhode IslandCompletedOvarian Cancer | brca1 Mutation Carrier | brca2 Mutation CarrierUnited States
-
Folkhälsan Researech CenterNärpes Health Care Center, Närpes, Finland; Department of Social Services and... and other collaboratorsCompleted
-
Turku University HospitalUniversity of Turku; University of Helsinki; Academy of Finland; European Foundation... and other collaboratorsUnknownType 2 Diabetes Mellitus | Healthy VolunteersFinland
-
Marja-Riitta TaskinenGöteborg UniversityCompletedType 2 Diabetes MellitusFinland
-
Abbott Diabetes CareRecruitingType 2 Diabetes Treated With InsulinFinland
-
University of OuluUniversity of Texas Southwestern Medical Center; Maastricht University; Finnish...Active, not recruitingType 2 DiabetesFinland
-
University of Eastern FinlandUnknown
-
Finnish Institute for Health and WelfareAcademy of FinlandCompleted
-
AstraZenecaAntaros Medical; Bioventure Hub; 43183 Mölndal; SwedenCompletedType 2 Diabetes MellitusFinland
-
VTT Technical Research Centre of FinlandCompletedHypertension | Diabetes Mellitus Type 2Finland
-
Kirsi PietiläinenTurku University Hospital; University of HelsinkiRecruitingType2 DiabetesFinland
-
Brown UniversityPfizer; LifespanTerminatedOvarian Cancer | Fallopian Tube Cancer | BRCA1 Mutation | BRCA2 Mutation | High Grade Serous CarcinomaUnited States
-
Helsinki University Central HospitalGöteborg UniversityCompleted
-
University of Eastern FinlandUniversity of Oslo; Karolinska Institutet; University of Copenhagen; University... and other collaboratorsRecruitingPhysical Activity | Type2 Diabetes | Diet Habit | Life Style | EmpowermentFinland
-
Turku University HospitalSmithKline BeechamCompletedType 2 Diabetes | Insulin SensitivityFinland
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusFinland, Netherlands, Sweden
-
Turku University HospitalLund UniversityCompletedObesity | Type 2 DiabetesFinland
-
Helsinki University Central HospitalUnknown
-
AstraZenecaCompleted
-
Tampere University HospitalTampere UniversityEnrolling by invitation
-
Finnish Institute for Health and WelfareUniversity of Eastern Finland; University of Oulu; Finnish Diabetes AssociationActive, not recruiting
-
Tampere UniversityCompletedHelicobacter Infections | Pancreatitis, AcuteFinland
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | BRCA1 Mutation Carrier | BRCA2 Mutation Carrier | Ovarian Epithelial TumorUnited States
-
Helsinki University Central HospitalUniversity of HelsinkiRecruitingCholera | Typhoid Fever | Vaccine-Preventable DiseasesFinland
-
University of TurkuGlaxoSmithKline; Sanofi Pasteur, a Sanofi CompanyCompleted
-
Finnish Institute for Health and WelfareEuropean Commission; Hospital District of Helsinki and UusimaaUnknownPrevalence of Psychoactive Substances in Road Traffic | Psychoactive Substances in Accident Involved Drivers | Relative Risk Estimation of Accident Involvement for Impaired DriversFinland
-
Turku University HospitalAntaros MedicalCompletedDiabetes Mellitus, Type 2Finland
-
Folkhälsan Researech CenterLund University; University of Padova; University of Pavia; Medtronic; Universidad... and other collaboratorsCompletedDiabetes Mellitus, Type 2Finland
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesFinland
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Finland
-
Helsinki University Central HospitalUnknownDiabetes Mellitus, Type 2 | Anticoagulant DrugsFinland
-
University of HelsinkiActive, not recruitingCardiovascular Diseases | Colorectal Cancer | Type2 DiabetesFinland
-
UKK InstituteUniversity of Eastern Finland; North Karelia Hospital DistrictUnknown
-
University of OuluOulu University HospitalCompleted
-
University of TurkuFazer; Aromtech Ltd.; Pakkasmarja; Saarioinen; Kiantama Ltd.; Satakunta Sea Buckthorn... and other collaboratorsCompletedAtherosclerosis | Type 2 DiabetesFinland
-
Helsinki University Central HospitalCompletedObesity | Metabolic Syndrome | Type 2 DiabetesFinland
-
Solvay PharmaceuticalsTerminatedType 2 Diabetes | DyslipidemiaFinland, Ireland, Italy
-
Sanofi Pasteur, a Sanofi CompanyCompletedMeningococcal InfectionsFinland
-
AstraZenecaTerminatedType 2 DiabetesItaly, Finland, United Kingdom
-
GlaxoSmithKlineCompletedTetanus | Diphtheria | Acellular PertussisFinland
-
GlaxoSmithKlineCompletedInfections, MeningococcalFinland
-
Sigrid Therapeutics ABCompletedOverweight | PreDiabetes | Prediabetic State | Type2 Diabetes | Obese | Type2 Diabetes Mellitus | Pre DiabetesFinland, Sweden
-
Tampere University HospitalTampere UniversityActive, not recruitingHyperglycemia | Diabetes Mellitus, Type 2 | Hypoglycemia | Cognitive Impairment | MoodFinland
-
Turku University HospitalUniversity of Turku; Kuopio University Hospital; University of Eastern FinlandRecruitingCardiovascular Diseases | Obesity | Diabetes Mellitus, Type 2 | Insulin Resistance | PreDiabetes | Lipid Metabolism DisordersFinland
-
University of NebraskaNational Cancer Institute (NCI)Active, not recruitingStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Invasive Breast Carcinoma | Stage IA Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | HER2/Neu Positive | Progesterone... and other conditionsUnited States
-
Helsinki University Central HospitalPfizerEnrolling by invitationLiver Cirrhosis | Diabetes Mellitus, Type 2 | NAFLDFinland
-
Finnish Institute for Health and WelfareNorwegian Institute of Public Health; Karolinska InstitutetCompletedCovid19 | SARS-CoV-2 InfectionFinland